Beam Therapeutics

Developer of gene therapy using CRISPR base editing to treat diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups340 employees language beamtx.com

Registered entities

Social engagement

Social engagement: 85.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Altitude Life Science Ventures, Google Ventures, Cormorant-asset, Redmile Group; 3 have since exited.

Investor typeCountShare
Venture capital1161%
Private equity16%
Other / undisclosed633%

Hiring activity

Hires frequently

8 roles tracked across 6 of the last 12 months

6 May 2026 · Associate Director / Director, Toxicology · Cambridge

31 Mar 2026 · Associate Director, Strategic Sourcing, Commercial and G&A · Cambridge

9 Mar 2026 · Clinical Trial Manager · Cambridge

22 Dec 2025 · Associate Director / Director, Medical Writing · Cambridge

13 Nov 2025 · Automation Validation Lead · Cambridge

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Milestone
anniversary
11 Jun 2026
Event
European Hematology Association (EHA) 2026
Coming soon